Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP).
Research Question: Is obesity associated with an increased incidence of VAP?
Study Design And Methods: This study was a post hoc analysis of the Impact of Early Enteral vs Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines (NUTRIREA2) open-label, randomized controlled trial performed in 44 French ICUs. Adults receiving invasive mechanical ventilation and vasopressor support for shock and parenteral nutrition or enteral nutrition were included. Obesity was defined as BMI ≥ 30 kg/m at ICU admission. VAP diagnosis was adjudicated by an independent blinded committee, based on all available clinical, radiologic, and microbiologic data. Only first VAP episodes were taken into account. Incidence of VAP was analyzed by using the Fine and Gray model, with extubation and death as competing risks.
Results: A total of 699 (30%) of the 2,325 included patients had obesity; 224 first VAP episodes were diagnosed (60 and 164 in obese and nonobese groups, respectively). The incidence of VAP at day 28 was 8.6% vs 10.1% in the two groups (hazard ratio, 0.85; 95% CI 0.63-1.14; P = .26). After adjustment on sex, McCabe score, age, antiulcer treatment, and Sequential Organ Failure Assessment at randomization, the incidence of VAP remained nonsignificant between obese and nonobese patients (hazard ratio, 0.893; 95% CI, 0.66-1.2; P = .46). Although no significant difference was found in duration of mechanical ventilation and ICU length of stay, 90-day mortality was significantly lower in obese than in nonobese patients (272 of 692 [39.3%] patients vs 718 of 1,605 [44.7%]; P = .02). In a subgroup of patients (n = 123) with available pepsin and alpha-amylase measurements, no significant difference was found in rate of abundant microaspiration of gastric contents, or oropharyngeal secretions between obese and nonobese patients.
Interpretation: Our results suggest that obesity has no significant impact on the incidence of VAP.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chest.2021.01.081 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of nasogastric versus orogastric tube placement on ventilator-associated pneumonia incidence in critically ill patients: a study protocol for a cluster randomised crossover trial in 16 intensive care units in France (SONG trial).
BMJ Open
September 2025
Service de Réanimation Polyvalente, Centre Hospitalier du Mans, Le Mans, France
Introduction: Patients in intensive care units (ICUs) frequently require mechanical ventilation, with approximately half needing invasive ventilation through an orotracheal tube. For these patients, gastric tube (GT) insertion is routinely performed to administer nutrition and medications or to drain gastric contents. The insertion route (oral or nasal) may affect the incidence of ventilator-associated pneumonia (VAP), a significant ICU care complication.
View Article and Find Full Text PDFTracheal tube cuff materials, shapes, and coatings in the prevention of ventilator-associated pneumonia: a network meta-analysis and systematic review.
Intensive Crit Care Nurs
August 2025
Shuguang Hospital Affliated to Shanghai University of Traditional Chinese Medicine, Clinical Research Center, Shanghai 201203, China. Electronic address:
Objectives: To compare the effectiveness of various endotracheal tube (ETT) cuff materials, shapes, and antimicrobial coatings in preventing ventilator-associated pneumonia (VAP) through a network meta-analysis.
Methods: Six databases were searched up to February 2025 for relevant randomized controlled trials (RCTs). Data analysis was performed using R software.
Assessment of the role of probiotics in prevention of ventilator-associated pneumonia in neonates.
Eur J Pediatr
September 2025
Pediatrics Department, Faculty of Medicine, Gharbia Governorate, El Bahr St., Tanta Qism 2, Tanta, 31527, Egypt.
Purpose: Ventilator-associated pneumonia (VAP) is a severe complication in NICUs. It increases morbidity, mortality, and healthcare costs. The research purpose was to evaluate the preventive value of probiotics on the incidence of VAP among ventilated neonates.
View Article and Find Full Text PDFGlucocorticoid Treatment in Hospital-Acquired and Ventilator-Associated Pneumonia.
Semin Respir Crit Care Med
September 2025
Nantes Universite, Nantes, France.
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) remain among the most frequent complications in critically ill patients. Despite the implementation of modern preventive strategies and the widespread use of broad-spectrum antibiotics, both the incidence and treatment failure rates remain high. However, no adjunctive therapy is currently recommended.
View Article and Find Full Text PDFImpact of early enteral nutrition on the prognosis of mechanically ventilated patients with chronic obstructive pulmonary disease: a retrospective cohort study based on the MIMIC-IV Database.
Front Nutr
August 2025
Department of Critical Care Medicine, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Background: While early enteral nutrition (EN) is recommended for critically ill patients, its specific impact on mechanically ventilated chronic obstructive pulmonary disease (COPD) patients remains uncertain.
Methods: We analyzed data extracted from the MIMIC-IV 3.0 database, focusing on patients with COPD who received invasive mechanical ventilation.